Gilead Sciences' sales fell 10% in the second quarter from a year earlier as the coronavirus pandemic weakened demand for some of its drugs, including some of its core hepatitis treatments.
The company declined to issue guidance for the second quarter in a row, but said on a call with analysts that it expects iPhone supply in the fall to be delayed for a few weeks.
United Parcel Service on Thursday reported a 13.4% rise in quarterly revenue, as the Covid-19 pandemic led to a surge in residential volumes and healthcare shipments.
Qualcomm stands to heavily benefit from 5G networks being built. It sells modem chips to phone makers, and licenses critical patents to anyone using 5G technology.
Spotify Technology missed quarterly revenue expectations on Wednesday and forecast a soft current quarter, due mainly to a decline in ads as the Covid-19 pandemic kept advertisers at bay.
Two competing narratives are battling it out this earnings season. One says the recovery is in trouble, another says the second quarter was the bottom.